Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
HIMS 
Hims Hers Health Inc (HIMS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/18/2025: HIMS (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
13 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $44.67
1 Year Target Price $44.67
| 4 | Strong Buy |
| 1 | Buy |
| 6 | Hold |
| 1 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 104.16% | Avg. Invested days 30 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 12/18/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 7.92B USD | Price to earnings Ratio 65.6 | 1Y Target Price 44.67 |
Price to earnings Ratio 65.6 | 1Y Target Price 44.67 | ||
Volume (30-day avg) 13 | Beta 2.41 | 52 Weeks Range 23.97 - 72.98 | Updated Date 12/19/2025 |
52 Weeks Range 23.97 - 72.98 | Updated Date 12/19/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.53 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 6.05% | Operating Margin (TTM) 2.06% |
Management Effectiveness
Return on Assets (TTM) 5.56% | Return on Equity (TTM) 26.21% |
Valuation
Trailing PE 65.6 | Forward PE 52.63 | Enterprise Value 8403617831 | Price to Sales(TTM) 3.58 |
Enterprise Value 8403617831 | Price to Sales(TTM) 3.58 | ||
Enterprise Value to Revenue 3.8 | Enterprise Value to EBITDA 53.36 | Shares Outstanding 219270891 | Shares Floating 205960440 |
Shares Outstanding 219270891 | Shares Floating 205960440 | ||
Percent Insiders 6.29 | Percent Institutions 94.43 |
Upturn AI SWOT
Hims Hers Health Inc
Company Overview
History and Background
Hims & Hers Health, Inc. was founded in 2017 by Andrew Dudum, Dustin Baker, and Jack Abendroth. It initially launched as 'Hims', a telehealth platform focused on men's wellness, offering prescription and over-the-counter treatments for hair loss, sexual health, and skincare. In 2019, the company expanded to include women's health services under the 'Hers' brand. Hims & Hers went public in January 2021 through a SPAC merger with Oaktree Acquisition Corp. II. The company has since expanded its offerings to include mental health services and a broader range of primary care services.
Core Business Areas
- Branded Prescriptions: Offers treatments for conditions such as hair loss (e.g., finasteride, minoxidil), erectile dysfunction (e.g., sildenafil, tadalafil), acne, and skincare. These are typically available through online consultations and subsequent prescription fulfillment.
- Over-the-Counter (OTC) Products: Provides a range of non-prescription products including shampoos, conditioners, topical treatments, vitamins, and supplements for hair health, skincare, and general wellness.
- Primary Care and Mental Health: Expanded services to include online consultations with primary care physicians and mental health professionals, offering therapy and prescription medication for conditions like anxiety and depression.
- Subscription Services: Many of its products and services are offered on a subscription basis, providing recurring revenue and customer retention.
Leadership and Structure
Hims Hers Health Inc. is led by CEO Andrew Dudum. The company operates on a direct-to-consumer (DTC) model, leveraging a technology platform to connect patients with healthcare providers and pharmacies.
Top Products and Market Share
Key Offerings
- Product Name 1: Hair Loss Treatments (Hims & Hers): This includes prescription medications like finasteride and minoxidil, as well as topical solutions and shampoos. Competitors include traditional pharmacies, specialized hair restoration clinics, and other telehealth providers like Ro and Keeps. Market share data is proprietary but represents a significant portion of their revenue. Number of users is in the hundreds of thousands.
- Product Name 2: Sexual Health Treatments (Hims): Primarily offers prescription medications such as sildenafil (Viagra) and tadalafil (Cialis) for erectile dysfunction. Competitors include other telehealth providers (e.g., Roman, Lemonaid Health) and traditional pharmacies. Number of users is in the hundreds of thousands.
- Product Name 3: Skincare and Acne Treatments (Hers): Includes prescription and OTC products for acne, anti-aging, and general skincare. Competitors include established skincare brands, dermatologists, and other telehealth platforms. Number of users is in the hundreds of thousands.
- Product Name 4: Mental Health Services (Hims & Hers): Offers online therapy sessions and prescription management for anxiety and depression. Competitors include platforms like BetterHelp, Talkspace, and Cerebral. Number of users is growing rapidly.
Market Dynamics
Industry Overview
Hims Hers Health Inc. operates within the rapidly growing telehealth and digital health market. This sector has seen significant expansion driven by increased consumer demand for convenient and accessible healthcare, coupled with technological advancements. The market is characterized by a shift towards personalized medicine, direct-to-consumer models, and a focus on chronic condition management and wellness.
Positioning
Hims & Hers is positioned as a leading direct-to-consumer telehealth platform specializing in personalized wellness solutions for men and women. Their competitive advantages lie in their strong brand recognition, integrated platform for consultations and prescriptions, subscription-based model for recurring revenue, and expansion into a wider range of health services beyond their initial focus areas. They benefit from the increasing acceptance of telehealth and the desire for discreet, convenient healthcare solutions.
Total Addressable Market (TAM)
The total addressable market for telehealth, men's and women's health, and mental health is vast and growing, estimated to be in the hundreds of billions of dollars globally. Hims & Hers is positioned to capture a significant share of this TAM by offering a comprehensive suite of services and continually expanding its product and service offerings to address evolving consumer needs in sexual health, hair loss, skincare, primary care, and mental wellness.
Upturn SWOT Analysis
Strengths
- Strong brand recognition and marketing prowess.
- Established direct-to-consumer (DTC) platform with a loyal customer base.
- Subscription-based revenue model for predictable income.
- Broad range of services covering multiple wellness categories.
- Scalable technology infrastructure.
Weaknesses
- Reliance on third-party pharmacies for prescription fulfillment.
- Potential for regulatory scrutiny and changes in telehealth policies.
- Intense competition in the digital health space.
- Customer acquisition costs can be high.
- Maintaining consistent quality of care across a large network of providers.
Opportunities
- Expansion into new geographic markets.
- Development of new product lines and treatment categories.
- Partnerships with employers and insurance providers.
- Leveraging AI and data analytics for personalized treatment plans.
- Growing consumer acceptance of telehealth and at-home healthcare solutions.
Threats
- Increased competition from established healthcare providers and new entrants.
- Changes in government regulations regarding telehealth and prescription drug sales.
- Data security breaches and privacy concerns.
- Economic downturns impacting consumer discretionary spending.
- Evolving consumer preferences and treatment outcomes.
Competitors and Market Share
Key Competitors
- Ro (RO)
- GoodRx Holdings Inc. (GDRX)
- CVS Health Corporation (CVS)
- Walgreens Boots Alliance, Inc. (WBA)
Competitive Landscape
Hims & Hers holds a significant position in the digital health and telehealth market, particularly in its niche areas. Its advantages include a strong brand and user-friendly platform. However, it faces intense competition from established pharmacies and other rapidly growing telehealth providers. The company's ability to differentiate through integrated services, customer experience, and competitive pricing will be crucial.
Growth Trajectory and Initiatives
Historical Growth: Hims & Hers has demonstrated strong historical revenue growth since its inception, driven by market expansion and diversification of its service offerings. The company has successfully scaled its operations and increased its customer base year-over-year.
Future Projections: Analyst projections for Hims & Hers generally indicate continued revenue growth, though the pace may moderate as the company matures and faces increased competition. Focus is expected to remain on expanding service lines, improving customer retention, and optimizing operational efficiency.
Recent Initiatives: Recent initiatives include the expansion of its primary care services, introduction of new mental health offerings, and a focus on increasing subscription uptake and average revenue per user (ARPU). The company is also investing in technology and data analytics to enhance personalization and customer experience.
Summary
Hims Hers Health Inc. is a prominent direct-to-consumer telehealth company with a strong brand and diversified service offerings in men's and women's wellness, including hair loss, sexual health, skincare, and mental health. The company has demonstrated robust revenue growth and a scalable business model. Its main strengths lie in its brand recognition and subscription revenue, while it faces challenges from intense competition and regulatory risks. Continued expansion into primary care and leveraging technology for personalized services are key to its future growth.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Hims Hers Health Inc. SEC Filings (10-K, 10-Q)
- Company Investor Relations
- Financial News Outlets (e.g., Wall Street Journal, Reuters)
- Market Research Reports (e.g., Statista, Grand View Research)
- Analyst Reports
Disclaimers:
This analysis is based on publicly available information as of the last update. Financial data and market share estimates are subject to change and may not be fully comprehensive. This information is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Hims Hers Health Inc
Exchange NYSE | Headquaters San Francisco, CA, United States | ||
IPO Launch date 2019-09-13 | Co-Founder, Chairman & CEO Mr. Andrew Dudum | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 1637 | Website https://www.hims.com |
Full time employees 1637 | Website https://www.hims.com | ||
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. The company also provides Labs which measures key markers over time and provides doctor-developed action plans. Hims & Hers Health, Inc. is based in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.